|
|
 | | | |
- close
- close
- close
- close
StreetInsider.com
May 7
Comment
Visit StreetInsider.com at http://www.streetinsider.com/Earnings/Akorn%2C+Inc.+%28AKRX%29+Misses+Q1+on+Top+and+Bottom/8310739.html for the full story.
Market Intelligence Center
Apr 10
Comment
Akorn Inc. (NASDAQ: AKRX) closed Tuesday's trading session at $13.37. In the past year, the stock has hit a 52-week low of $10.53 and 52-week high of $16.87. Akorn (AKRX) stock has been showing support around $13.25 and resistance in the $13.61...
Market Intelligence Center
Mar 25
Comment
Akorn Inc. (NASDAQ: AKRX) closed Friday's trading session at $13.30. In the past year, the stock has hit a 52-week low of $10.53 and 52-week high of $16.87. Akorn (AKRX) stock has been showing support around $13.14 and resistance in the $13.52...
Benzinga
Mar 15
Comment
Below are the top drugs-generic stocks on the NYSE and the NASDAQ in terms of profit margin.
The trailing-twelve-month profit margin at Hi Tech Pharmacal Co (NASDAQ: HITK) is 15.77%. Hi Tech Pharmacal's ROE for the same period is 15.20%.
The...
StreetInsider.com
Feb 26
Comment
Visit StreetInsider.com at http://www.streetinsider.com/Earnings/Akorn%2C+Inc.+%28AKRX%29+Tops+Q4+EPS+by+1c/8131632.html for the full story.
StreetInsider.com
Jan 28
Comment
Visit StreetInsider.com at http://www.streetinsider.com/Upgrades/RBC+Capital+Upgrades+Akorn+%28AKRX%29+to+Sector+Perform/8033832.html for the full story.
StreetInsider.com
Jan 17
Comment
Visit StreetInsider.com at http://www.streetinsider.com/Guidance/Akorn+%28AKRX%29+Guides+FY13+adj.-EPS+Below+Views%2C+Revs+In-Line%3B+Reaffirms+FY12/8015895.html for the full story.
Benzinga
Nov 29
Comment
Below are the top drugs-generic stocks on the NASDAQ in terms of return on equity.
The trailing-twelve-month return on equity at Akorn (NASDAQ: AKRX) is 18.99%. Akorn's revenue for the same period is $227.26 million.
The...
Benzinga
Nov 7
Comment
In a report published Wednesday, Deutsche Bank reiterated its Hold rating on Akorn (NASDAQ: AKRX), but slightly lowered its price target from $14.00 to $13.00.
Deutsche Bank noted, “Q3 EPS A Penny Better– Benefiting from Lower R&D, Higher...
StreetInsider.com
Nov 6
Comment
Visit StreetInsider.com at http://www.streetinsider.com/Earnings/Akorn%2C+Inc.+%28AKRX%29+Tops+Q3+EPS+by+1c%3B+Reaffirms+FY12+Outlook/7847057.html for the full story.
Suggest other news sources for this topic
more ▼WIKI ANALYSIS
WIKI ANALYSIS
 |
The article on this company has not been written yet. If you're the first person to write this article, it's a sure thing that you'll be credited as a Top Contributor. For tips on getting started, check out the sample article. |
References
| |||||||
